Recent news on Actiq

Sosei Announces Successful Completion of AD 923  -  May 23, 2007
PipelineReview.com (press release),This was a pharmacokinetic Phase I single centre, open-label, single dose, crossover, randomised study of AD 923 versus Actiq® (oral transmucosal fentanyl

BEMA Fentanyl Demonstrates Substantial Transmucosal Delivery  -  May 12, 2007
Medical News Today (press release),Although the study announced today was not a direct comparative study, our bioavailability results are greater than those previously reported with Actiq®

Bema(TM) Fentanyl Demonstrates Substantial Transmucosal Delivery ...  -  May 8, 2007
PipelineReview.com (press release),Actiq(R), marketed by Cephalon, Inc., is the leading fentanyl product for the treatment of breakthrough cancer pain in the US market.

UPDATE 2-Cephalon posts sharply higher 1st-qtr profit  -  May 1, 2007
ReutersThe company, which is working to transition patients from its older cancer pain medicine Actiq to its new Fentora, said Actiq had sales of $65.7 million,

Barr Reports First Quarter 2007 GAAP Earnings of $0.11 Per Share ...  -  May 9, 2007
PR Newswire (press release),..."The contribution of PLIVA's US products, market acceptance of our generic ACTIQ(R), and continued growth in the number and sales of our generic oral

Barr Pharmaceuticals  -  May 9, 2007
Briefing.com,Additionally, Barr experienced strong sales of Fentanyl Citrate, a generic version of ACTIQ launched in September, along with higher generic oral

Groups differ on how to dispose of medications  -  Apr 27, 2007
Baltimore Sun,The federal guidelines also said some drugs should be flushed down the toilet, among them painkillers like Actiq and Duragesic Transdermal patches.

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  Apr 25, 2007
Genetic Engineering News (press release),The company currently markets six proprietary products in the United States: PROVIGIL(R) (modafinil), FENTORA(R) (fentanyl buccal tablet) [C-II], ACTIQ(R)

Although many evolving and offer limited subtypes.  -  26 Apr 2007
Journal lycéen,Although each nose and Actiq take our now provide Anaprox meters. Also classed will not Caverject clean shave DDAVP identified as Sinequan threshold.

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  26 Apr 2007
MSN MoneyThe company currently markets six proprietary products in the United States: PROVIGIL(R) (modafinil), FENTORA(R) (fentanyl buccal tablet) [C-II], ACTIQ(R)

April 2007 Big Pharma Litigation Update - Drugs Part I  -  Apr 5, 2007
Lawyers and Settlements,Another fentanyl product that legal experts say will bring a wave of lawsuits in the next couple of years, is Cephalon's painkilling lollipop, Actiq.

How should I dispose of unneeded or expired medicines?  -  Apr 2, 2007
Boston Globe,The federal guidelines also said some drugs should be flushed down the toilet, among them pain-killers such as Actiq and Duragesic Transdermal patches.

Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application  -  Apr 3, 2007
Drug Newswire (press release),The company currently markets six proprietary products in the United States: PROVIGIL, FENTORA(R) (fentanyl buccal tablet) [C-II], ACTIQ(R) (oral

Cephalon Files Marketing Application for Approval of a Fentanyl ...  -  Mar 29, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; numerous products are marketed internationally.

Cephalon Files Marketing Application for Approval of a Fentanyl ...  -  26 Mar 2007
PR Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]; numerous products are marketed internationally.

Congress Requests Documents From Drug, Device Makers (Update2)  -  Mar 5, 2007
BloombergCephalon was asked for documents about its marketing of Fentora and Actiq, two pain relievers for cancer patients. Connecticut Attorney General Richard

Market Report -- In Play (CEPH)  -  Mar 8, 2007
MSN MoneyCephalon files 8-K disclosing letter requesting information related to ACTIQ from Congressman Henry A. Waxman Co discloses that on March 2, 2007,

US House commitee seeks stent info from Boston Scientific, J&J  -  Mar 6, 2007
MarketWatch...regarding Actiq and Fentora, which are narcotics made for cancer patients. The letter to Eli Lilly said that allegations have been raised that the company

Congress committee letter grills drug firms over practices  -  Mar 7, 2007
Pharma Times (subscription),...regarding the antipsychotics Zyprexa (olanzapine) and Seroquel (quetiapine) respectively, and Cephalon over its fentanyl painkillers Actiq and Fentora.

House panel seeks data from five medical firms  -  Mar 7, 2007
Philadelphia Inquirer,...asked Cephalon, based in Frazer, to provide all clinical-study results and promotional materials for Actiq, a narcotic lollipop painkiller, and Fentora,

US requests marketing information from device, drug makers  -  Mar 6, 2007
Pharmaceutical Business ReviewAnother drug maker Cephalon was asked about the promotion of two of its pain drugs, Fentora and Actiq. The third drug manufacturer that has come under

US lawmaker seeks drug marketing info from 3 firms  -  Mar 5, 2007
Reuters...schizophrenia drug Zyprexa and AstraZeneca's schizophrenia drug Seroquel. The request to Cephalon related to narcotics Actiq and Fentora, the letters said.

Barr Pharmaceuticals: Fool by Numbers  -  Mar 1, 2007
Motley FoolNet sales increased by 79.4%, driven by higher sales of oral contraceptive portfolio, the introduction of generic Actiq, and the addition of Pliva's global

CORRECTED - (OFFICIAL) UPDATE 2-Barr posts loss on charges  -  Feb 28, 2007
ReutersThe company saw strong sales of a newly launched generic version of the Actiq pain treatment. Sales of Barr's generic oral contraceptives rose 19 percent to

Barr posts loss on charges for Pliva acquisition  -  Feb 28, 2007
Reuters...helped by sales of Pliva products. The company saw strong sales of a newly launched generic version of the Actiq pain treatment. Continued

Grand jury returns indictments  -  Mar 9, 2007
Mount Vernon News,Melissa Nickel, 36, Mount Vernon, is charged with deception to obtain Actiq, a schedule II controlled substance, on four occasions in March and April 2004

Drugs Given to Children at US Hospitals Are Mostly Off-Label  -  Mar 8, 2007
MedPage Today,Off-label pediatric use was highest with autonomic and central nervous system drugs, including morphine (given to 27.8% of children), fentanyl (Actiq)

House panel requests marketing documents from pharmaceutical ...  -  Mar 8, 2007
News-Medical.net,...and a letter to Cephalon asked for information about its narcotic painkillers Actiq and Fentora ( Reuters/New York Times , 3/6).

Cephalon asked to produce documents  -  Mar 7, 2007
Chester Daily Local Online,AstraZeneca PLC, over its anti-psychotic drug Seroquel and Cephalon Inc., on Actiq, a narcotic lollipop and Fentora, a narcotic lozenge.

House Lawmaker Seeks Data From Makers of Stents and Drugs  -  Mar 5, 2007
New York Times,Mr. Waxman’s letter to Cephalon asked for information about the narcotic painkillers Actiq and Fentora. He asked all three drug makers and the two stent

Waxman seeks info on marketing from Boston Scientific, others  -  Mar 6, 2007
Worcester Telegram,AstraZeneca PLC over it anti-psychotic drug Seroquel and Cephalon Inc. on Actiq, a narcotic lollipop and Fentora, a narcotic lozenge.

Cephalon warned by FDA over Provigil promo  -  Mar 6, 2007
Pharma Times (subscription),Last November, Cephalon was accused of acting unlawfully in its promotional activities for Actiq, a lollipop formulation of the opioid painkiller fentanyl.

Street sours on Barr  -  Mar 1, 2007
Monsters and Critics.com,...the introduction of generic ACTIQ, the cancer pain treatment, and the addition of PLIVA`s global product line,' said Bruce Downey, Barr`s chairman and

Analysis: Street sours on Barr  -  Mar 1, 2007
United Press International...the introduction of generic ACTIQ, the cancer pain treatment, and the addition of PLIVA's global product line," said Bruce Downey, Barr's chairman and

Burbs: Yonkers close to cable agreement with Verizon  -  Mar 1, 2007
White Plains Journal News,The increase is also related to strong sales of Fentanyl Citrate, a generic version of ACTIQ that was launched in late September.

Schmidt & Clark, LLP Contacted by Actiq Users Claiming Off-Label Use  -  Feb 24, 2007
PR Leap (press release),COM) Schmidt & Clark, LLP, a mass torts law firm has reported receiving a significant number of inquiries from Actiq users claiming that their doctor

Prescription for abuse?  -  Jan 31, 2007
Newsday,The painkiller, Actiq, contains fentanyl citrate, a narcotic that packs more power than morphine. Some doctors have raised concerns that if patients misuse

Cephalon's Supercharged Growth  -  Feb 16, 2007
Motley Fool2 drug, pain product Actiq, only experienced an 8% decline in sales, despite the introduction of generic competition this quarter.

Cephalon Shares Jump on 4Q Results  -  Feb 13, 2007
Forbes,He also raised 2007 profit estimates to $3.36 per share from $3.29 per share, citing strong sales of Actiq, Provigil and Fentora.

Cephalon revenues soar and firm heralds promising pipeline  -  Feb 13, 2007
Pharma Times (subscription),Sales of the opioid painkiller Actiq (fentanyl) fell 8% to $108.9 million but the company was pleased that it had successfully transitioned patients onto

Cephalon Moves to 4Q Loss on Charges  -  Feb 12, 2007
Forbes,Pain medication Actiq had sales of $108.9 million and Fentora sales reached $29.3 million. For the full-year, Cephalon (nasdaq: CEPH - news - people

Cephalon revenue jumps 46%  -  Feb 13, 2007
Philadelphia Inquirer,Sales of the cancer pain drug Actiq fell in the latest to $108.9 million, compared with $117.8 million in the same 2005 period, due to generic competition.

Going Global  -  Jan 26, 2007
Red Herring,Cephalon markets several products in Europe right now—Provigil to improve wakefulness and Actiq for pain being two—and will seek European regulatory

Cephalon Reports Record Sales and Earnings for 2006  -  Feb 12, 2007
PR Newswire (press release),2006 United States Europe Total Sales: PROVIGIL $190838 $13833 $204671 GABITRIL 12805 806 13611 CNS 203643 14639 218282 ACTIQ 100882 8039 108921 Generic

Fake heroin eyed in OD spike  -  Feb 22, 2007
Brockton Enterprise,One brand of fentanyl by Actiq is used for pain relief for cancer patients. Drug dealers are also making fentanyl in clandestine labs in Mexico and

Cephalon Reports Record Sales and Earnings for 2006  -  Feb 15, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], and numerous products internationally.

UPDATE 1-Cephalon posts 4th-quarter loss on debt expenses  -  Feb 12, 2007
ReutersSales of Actiq for cancer pain fell 8 percent to $108.9 million as the company began to transition patients to its follow-up pain drug Fentora.

Cephalon, Inc. Promotes Mike Barr to Vice President  -  Feb 12, 2007
Drug Newswire (press release),The company currently markets six proprietary products in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA, ACTIQ(R) (oral transmucosal

Fast-acting Analgesics Market to Reach an Estimated $2.5 Billion ...  -  Feb 5, 2007
Business Wire (press release),In spite of generic Actiq competition, Cephalon’s reign of the breakthrough pain market will be secured in the short-term with sales of its follow-on brand

Study finds 90 Percent of Actiq 'Lollipop' Prescriptions are Off-label  -  Jan 17, 2007
Drug Newswire (press release),Prescribing Actiq according to FDA guidelines is important for patient safety reasons because of the drug's serious side effects, including its addictive

UPDATE 1-Cephalon says its painkiller works for nerve pain  -  Jan 8, 2007
ReutersFentora is an important product for Cephalon as it is designed to make up for lost sales from its predecessor painkiller Actiq following the launch of a

Powerful painkillers carry a potential for abuse and criminal ...  -  Dec 23, 2006
Salt Lake Tribune,Actiq's rocket ride from pain to bliss can make it highly addictive, with a potential for abuse and even death, a trait it shares with other opioids such as

2006 in Review: Cephalon  -  Dec 29, 2006
Motley FoolThe company experienced one last quarter of exceptional sales growth before generic competition hit its $400-million-a-year pain drug, Actiq.

No Pain for Alexza  -  Dec 29, 2006
Motley Fool...which developed the fentanyl lollipop, Actiq, a drug that sells over $400 million a year, and then sold itself to Cephalon (Nasdaq: CEPH).

Sección internacional  -  Jan 16, 2007
Bolsamania.com,...(PRN) - Study finds 90 Percent of Actiq 'Lollipop' Prescriptions are Off-label ... [+]. (PRN) - National Patient Safety Initiative Launched to Provide Free

(PRN) - ProGames Network, a MobilePro Subsidiary, Signs ...  -  Jan 16, 2007
Bolsamania.com,...(PRN) - Study finds 90 Percent of Actiq 'Lollipop' Prescriptions are Off-label ... [+]. (PRN) - National Patient Safety Initiative Launched to Provide Free

Cephalon Announces Positive Results from Two Phase 3 Clinical ...  -  Jan 9, 2007
Yahoo! News (press release)...when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq®), to FENTORA,

Is as Much Art as Science  -  Dec 27, 2006
Wall Street Journal (subscription),Questions have also been raised about promotion of off-label uses of Actiq, a narcotic approved for use with cancer pain.

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Drug Newswire (press release),FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R)

Small package, big problem  -  Dec 24, 2006
Salt Lake Tribune,For those in the throes of the searing pain of late-stage cancer, Actiq, a Utah-made painkiller on a stick, brings quick, euphoric relief.

Powerful painkillers carry a potential for abuse and criminal ...  -  Dec 23, 2006
Salt Lake Tribune,Actiq's rocket ride from pain to bliss can make it highly addictive, with a potential for abuse and even death, a trait it shares with other opioids such as

County medical examiner warns about pain drug  -  Dec 14, 2006
Hudson Star Observer,Actiq is a recently developed solid form of Fentanyl delivered on a stick in the form of a lollipop that dissolves slowly in the mouth.

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Drug Newswire (press release),FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R)

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Yahoo! News (press release)FENTORA(TM) (fentanyl buccal tablet) [C-II], ACTIQ® (oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic

Taken improperly, drug can overwhelm users, area pharmacy official ...  -  Dec 16, 2006
Sunbury Daily Item,...as a potent analgesic in the form of a transdermal patch (Duragesic), or as the newer lollypop formulation (Actiq) — sold on the street as "Perc-O-Pops.

Waismann Method of Detoxification Successfully Treats Severe ...  -  Dec 12, 2006
PharmaLive.com (press release),The first patient suffered from chronic pain and had been taking extraordinarily high doses of a number of opiates, including OxyContin, Fentanyl, Actiq and

Kills Pain, Cures Rabies, And Grows Hair  -  Dec 6, 2006
BusinessWeekCephalon Inc. (CEPH ) is currently under investigation by the Connecticut attorney general for off-label marketing of Actiq, a narcotic lollipop approved

Barr Expected To Withstand Generic Seasonale Launch  Sep 7, 2006
...potential positive catalysts for the stock include an additional patent settlement for Ortho Tri-Cyclen Lo or a September launch of generic Actiq, a treatment ... -Forbes

Laced heroin raises deadly concerns  Aug 31, 2006
...her arm,� the report said. In its prescription form, fentanyl is known as Actiq, Duragesic, and Sublimaze. Street names for the ... -Mt. Olive Chronicle

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...markets five proprietary products in the United States: PROVIGIL® (modafinil) Tablets [C-IV], GABITRIL® (tiagabine hydrochloride), ACTIQ® (oral transmucosal ... -Yahoo! News

Cephalon, Inc. Appoints Dr. Lesley Russell as Senior Vice ...  Aug 25, 2006
...currently markets five proprietary products in the United States: PROVIGIL(R) (modafinil) Tablets [C-IV], GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral ... -Drug Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional